DEL ROSSO, J. .; YOSIPOVITCH, G. .; STÄNDER, S. .; SILVERBERG, J. .; WOLLENBERG, A. .; LIO, P. A. .; CARRASCOSA, J. M. .; GALLO, G. .; CASILLAS, M. .; PIERCE, E. .; DING, Y. .; XU, Z. .; AGELL, H. .; STEIN GOLD, L. . Lebrikizumab Provides Stable Itch Response With No or Minimal Fluctuations up to One Year in Patients With Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 6, p. s282, 2023. DOI: 10.25251/skin.7.supp.282. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/2390. Acesso em: 3 jul. 2024.